Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Why that unprescribed drug could make you resistant to other drugs in future

11 September 2026 · By · Wire by Fusion42

Published

11 September 2026

Topic

opportunities

◆ Sectors

Health

◆ Geography

Kenya

◆ Source

Read at nation.africa →

◆ Verified

Fusion42 · 11 September 2026 · Fusion42 review

Kenya is addressing the growing threat of antimicrobial resistance driven by misuse of drugs across human health, agriculture, and the environment through a multisectoral One Health approach, aiming for sustainable government financing and coordinated policy response.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

You must factor Kenya’s coordinated One Health policies into your drug development or health tech strategy as government financing and regulation tighten on antimicrobial use across sectors. This creates new openings for solutions that integrate human, animal, and environmental data to tackle resistance.

◆ Coverage

1 source · 11 Sep 2026

◆ Related on Wire

◆ Topics

Healthantimicrobial-resistanceone-healthkenyapublic-healthdrug-policy